1164 – Advancing Purification Technologies and Process Innovations to Support High rAAV Upstream Productivity and Meet Growing Industry DemandDownload
2164 – From Development to Commercialization: Late-Stage Process Characterization for rAAV ManufacturingDownload

Our Presence at the 2026 ASGCT Annual Meeting
We look forward to connecting with the cell and gene therapy community in Boston! You can connect with our AAV experts by attending our panel, or by planning a private meeting. Check out our Forge-specific activities each day:
- May 12-14
- Find us on the show floor at Booth #1349
- Tuesday, May 12th
- 3:30 PM | Exhibit Hall
- Tools and Technologies Forum: Validation of AUC assay to characterize AAV empty to full capsid ratio
- 5:00 PM | Posters
- 1164 – Advancing Purification Technologies and Process Innovations to Support High rAAV Upstream Productivity and Meet Growing Industry Demand
- 1233 – The role of a drug master file in multi-program data sharing and improving review efficiency.
- 6:30 PM | ASGCT Momentum Gala
- Supporting sponsor
- 3:30 PM | Exhibit Hall
- Wednesday May 13
- 10:15-10:45 AM | Room 109AB
- Sponsored Symposium: More Doses, Same Run: Process Innovation and Late-Phase Manufacturing Frameworks for AAV Developers
- 5:00 PM | Poster
- 2164 – From Development to Commercialization: Late-Stage Process Characterization for rAAV Manufacturing
- 6:00 PM | Forge Reception
- Contact your client representative for details
- 10:15-10:45 AM | Room 109AB
- Thursday May 14
- 5:00 PM | Poster
- 3145 – Advancing High-Yield Suspension HEK293 rAAV Manufacturing in Single-Use Bioreactors
- 5:00 PM | Poster